IGF1R and pancreatic neoplasm: Moreover, despite no correlation in the normal pancreas (R = 0.07, p = 0.39) between GHR and IGF2 (a potent activator of IGF1R), a much higher positive correlation in pancreatic tumors is observed (R = 0.37, p < 0.001) for the same (Figure 1C).